Author

Oleg E Tolmachov

University of Greenwich, UK - Cited by 877 - Gene Therapy - Cell Therapy - Swarm Intelligence - Nanodevices

Biography

Dr Oleg Tolmachov is working as a Research Associate in the Section of Molecular Medicine at the National Heart and Lung Institute, Imperial College London, UK. He completed his PhD in Genetics.  
Title
Cited by
Year
An araC-controlled bacterialcre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy
BW Bigger, O Tolmachov, JM Collombet, M Fragkos, I Palaszewski, ...Journal of Biological Chemistry 276 (25), 23018-23027, 2001200
185
2001
Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo
T Tolmachova, OE Tolmachov, AR Barnard, SR de Silva, DM Lipinski, ...Journal of molecular medicine 91, 825-837, 2013201
85
2013
Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver
O Argyros, SP Wong, C Fedonidis, O Tolmachov, SN Waddington, ...Journal of molecular medicine 89, 515-529, 2011201
81
2011
Nuclear‐targeted minicircle to enhance gene transfer with non‐viral vectors in vitro and in vivo
L Vaysse, LG Gregory, RP Harbottle, E Perouzel, O Tolmachov, ...The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2006200
57
2006
Development of a self-assembling nuclear targeting vector system based on the tetracycline repressor protein
L Vaysse, R Harbottle, B Bigger, A Bergau, O Tolmachov, C CoutelleJournal of Biological Chemistry 279 (7), 5555-5564, 2004200
50
2004
CHM/REP1 cDNA delivery by lentiviral vectors provides functional expression of the transgene in the retinal pigment epithelium of choroideremia mice
T Tolmachova, OE Tolmachov, ST Wavre‐Shapton, D Tracey‐White, ...The journal of gene medicine 14 (3), 158-168, 2012201
50
2012
Designing plasmid vectors
O TolmachovGene Therapy of Cancer: Methods and Protocols, 117-129, 2009200
48
2009
Overexpression of connexin 43 using a retroviral vector improves electrical coupling of skeletal myoblasts with cardiac myocytes in vitro
O Tolmachov, YL Ma, M Themis, P Patel, H Spohr, KT MacLeod, ...BMC cardiovascular disorders 6 (1), 1-11, 2006200
46
2006
Silencing of transgene expression: A gene therapy perspective
OE Tolmachov, T Subkhankulova, T TolmachovaGene Therapy - Tools and Potential Applications, 49-68, 2013201
32
2013
Remarkable stability of an instability-prone lentiviral vector plasmid in Escherichia coli Stbl3
FA Al-Allaf, OE Tolmachov, LP Zambetti, V Tchetchelnitski, H Mehmet3 Biotech 3, 61-70, 2013201
29
2013
Building mosaics of therapeutic plasmid gene vectors
O E TolmachovCurrent gene therapy 11 (6), 466-478, 2011201
28
2011
Hhex and Cer1 Mediate the Sox17 Pathway for Cardiac Mesoderm Formation in Embryonic Stem Cells
Y Liu, R Kaneda, TW Leja, T Subkhankulova, O Tolmachov, G Minchiotti, ...Stem cells 32 (6), 1515-15, 2014201
26
2014
RecET driven chromosomal gene targeting to generate a RecA deficient Escherichia colistrain for Cre mediated production of minicircle DNA
O Tolmachov, I Palaszewski, B Bigger, C CoutelleBmc Biotechnology 6 (1), 1-12, 2006200
17
2006
Designing lentiviral gene vectors
OE Tolmachov, T Tolmachova, FA Al-AllafViral Gene Therapy, 263-284, 2011201
16
2011
Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA
OE TolmachovMedical hypotheses 74 (4), 702-704, 2010201
16
2010
Methods of Transfection with Messenger RNA Gene Vectors
OE Tolmachov, T TolmachovaGene Therapy - Principles and Challenges, 37-56, 2015201
14
2015
Covalent attachment of multifunctional chimeric terminal proteins to 5′ DNA ends: A potential new strategy for assembly of synthetic therapeutic gene vectors
O Tolmachov, C CoutelleMedical hypotheses 68 (2), 328-331, 2007200
10
2007
Novel ChIP-seq simulating program with superior versatility: isChIP
T Subkhankulova, F Naumenko, OE Tolmachov, YL OrlovBriefings in Bioinformatics 22 (4), bbaa352, 2021202
9
2021
Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: A new concept for improvement of non-viral therapeutic gene delivery
OE TolmachovMedical Hypotheses 8 (5), 632-635, 2012201
7
2012
Methods of making minicircles
B Bigger, O Tolmachov, C CoutelleUS Patent App. 11/249,929, 2006200
7
2006

Referred From: https://scholar.google.com/citations?user=PZhaceoAAAAJ&hl=en

Cited by
Citations 877
h-index 16
i10-index 18
Recommended Journals
Open Access Journals